Profile data is unavailable for this security.
About the company
Max Healthcare Institute Limited is an India-based integrated healthcare provider. The Company operates through a single segment, which is Medical and Healthcare Services. It provides a wide array of services ranging from primary to quaternary care, including advanced cardiac care, orthopaedics, oncology, neurosciences, transplants, minimal access metabolic and bariatric surgery, and other services, including obstetrics and gynaecology, paediatrics and nephrology. The Company also provides outpatient services, including consultations for a range of ailments, preventive health screenings, and laboratory services as well as radiology, imaging and emergency services. The Company has two strategic business units (SBUs): Max Lab and Max@Home. The Company owns and operates approximately 22 healthcare facilities across the Delhi NCR, Haryana, Punjab, Uttarakhand, Maharashtra, and Uttar Pradesh. It also offers diagnostic services to patients outside its network.
- Revenue in INR (TTM)60.08bn
- Net income in INR10.59bn
- Incorporated2001
- Employees4.05k
- LocationMax Healthcare Institute Ltd2nd FloorCapital Cyberscape,, Sector-59,GURGAON 122011IndiaIND
- Phone+91 2 226101035
- Fax+91 1 126510050
- Websitehttps://www.maxhealthcare.in/
Mergers & acquisitions
| Acquired company | MAXHEALTH:NSI since announced | Transaction value |
|---|---|---|
| Jaypee Healthcare Ltd | 10.13% | 27.06m |
| Jaypee Healthcare Ltd | 10.13% | 47.43m |
| Alexis Multi Speciality Hospital Pvt Ltd | 14.28% | 49.65m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aster DM Healthcare Ltd | 16.42bn | 2.51bn | 213.23bn | 14.02k | 88.02 | 6.21 | 54.75 | 12.98 | 4.86 | 108.08 | 32.21 | 68.98 | 0.1467 | 1.20 | 1.26 | 1,171,811.00 | 2.85 | 2.24 | 4.16 | 3.60 | 40.82 | 59.73 | 19.40 | 4.26 | 1.82 | 7.41 | 0.3501 | -- | 23.54 | -14.22 | 12.28 | -18.15 | 6.87 | -- |
| Krishna Institute Of Medical Sciencs Ltd | 27.05bn | 3.31bn | 233.68bn | 5.01k | 70.56 | 11.67 | 44.46 | 8.64 | 8.28 | 8.28 | 67.59 | 50.03 | 0.6765 | 10.76 | 8.26 | 5,396,635.00 | 9.10 | 13.71 | 11.33 | 16.73 | 79.37 | 54.29 | 13.45 | 15.53 | 0.8678 | 8.11 | 0.4384 | 0.00 | 13.67 | 22.17 | -7.78 | -- | 52.94 | -- |
| Dr. Lal PathLabs Ltd | 23.46bn | 4.01bn | 252.08bn | 4.10k | 62.83 | 12.59 | 45.90 | 10.74 | 48.17 | 48.17 | 281.60 | 240.30 | 0.9306 | 10.55 | 26.72 | 5,724,423.00 | 16.13 | 15.49 | 20.12 | 19.38 | 80.28 | 76.13 | 17.33 | 15.99 | 2.77 | 20.16 | 0.0889 | 23.86 | 10.40 | 13.10 | 49.78 | 12.43 | 6.44 | 31.95 |
| Narayana Hrudayalaya Ltd | 52.21bn | 7.79bn | 255.69bn | 11.66k | 32.83 | 8.03 | 24.73 | 4.90 | 38.35 | 38.35 | 257.10 | 156.86 | 0.9466 | 20.96 | 9.50 | 4,477,685.00 | 14.13 | 10.79 | 18.08 | 13.97 | 60.92 | 47.11 | 14.92 | 9.72 | 1.46 | 7.62 | 0.3468 | 9.64 | 10.91 | 11.89 | 30.19 | 67.89 | 45.27 | 31.95 |
| Fortis Healthcare Ltd | 73.13bn | 6.56bn | 513.90bn | 2.59k | 78.41 | 6.55 | 48.05 | 7.03 | 8.68 | 8.68 | 96.80 | 103.94 | 0.5544 | 14.45 | 9.84 | 28,202,260.00 | 5.34 | 3.54 | 7.68 | 4.57 | 76.46 | 73.04 | 9.63 | 7.63 | 0.4369 | 8.57 | 0.1197 | 8.90 | 9.45 | 9.05 | 1.72 | -- | 62.52 | -- |
| Max Healthcare Institute Ltd | 60.08bn | 10.59bn | 962.56bn | 4.05k | 91.32 | 10.94 | 71.24 | 16.02 | 10.84 | 10.84 | 61.52 | 90.51 | 0.5053 | 15.02 | 12.53 | 14,846,260.00 | 8.91 | 6.98 | 10.05 | 8.06 | 79.38 | 76.77 | 17.63 | 15.02 | 1.20 | 14.69 | 0.1673 | 3.34 | 18.49 | 26.17 | -4.16 | -- | 46.69 | -- |
| Apollo Hospitals Enterprise Limited | 204.69bn | 11.83bn | 969.47bn | 82.79k | 81.94 | 12.92 | 50.63 | 4.74 | 82.29 | 82.29 | 1,423.72 | 521.69 | 1.17 | 24.23 | 7.29 | 2,472,568.00 | 6.82 | 5.48 | 9.37 | 7.13 | 48.41 | 48.52 | 5.85 | 4.82 | 1.38 | 4.35 | 0.4822 | 21.94 | 14.73 | 14.66 | 9.71 | 30.65 | -- | 21.67 |
| Holder | Shares | % Held |
|---|---|---|
| Capital Research & Management Co. (World Investors)as of 07 Nov 2024 | 106.78m | 10.98% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 26.85m | 2.76% |
| SBI Funds Management Ltd.as of 30 Jun 2024 | 23.07m | 2.37% |
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Oct 2024 | 21.53m | 2.22% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 19.83m | 2.04% |
| Canara Robeco Asset Management Co. Ltd.as of 31 Oct 2024 | 15.82m | 1.63% |
| Fidelity Management & Research (Hong Kong) Ltd.as of 30 Sep 2024 | 10.69m | 1.10% |
| Wasatch Advisors LPas of 30 Sep 2024 | 10.31m | 1.06% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Oct 2024 | 10.17m | 1.05% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 8.19m | 0.84% |
